These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9032889

  • 21. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine.
    Greenway TE, Eldridge JH, Ludwig G, Staas JK, Smith JF, Gilley RM, Michalek SM.
    Vaccine; 1995; 13(15):1411-20. PubMed ID: 8578818
    [Abstract] [Full Text] [Related]

  • 22. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
    Honko AN, Sriranganathan N, Lees CJ, Mizel SB.
    Infect Immun; 2006 Feb; 74(2):1113-20. PubMed ID: 16428759
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague.
    Williamson ED, Bennett AM, Perkins SD, Beedham RJ, Miller J, Baillie LW.
    Vaccine; 2002 Jul 26; 20(23-24):2933-41. PubMed ID: 12126905
    [Abstract] [Full Text] [Related]

  • 25. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
    Tripathi V, Chitralekha KT, Bakshi AR, Tomar D, Deshmukh RA, Baig MA, Rao DN.
    Vaccine; 2006 Apr 12; 24(16):3279-89. PubMed ID: 16476510
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection.
    Hickey DK, Aldwell FE, Tan ZY, Bao S, Beagley KW.
    Vaccine; 2009 Nov 23; 27(50):6983-90. PubMed ID: 19800441
    [Abstract] [Full Text] [Related]

  • 30. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M, Cai L.
    Viral Immunol; 2001 Nov 23; 14(1):31-47. PubMed ID: 11270595
    [Abstract] [Full Text] [Related]

  • 31. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK, Aldwell FE, Beagley KW.
    Vaccine; 2009 Oct 19; 27(44):6217-25. PubMed ID: 19698810
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model.
    Shreewastav RK, Ali R, Uppada JB, Rao DN.
    Cell Immunol; 2012 Oct 19; 278(1-2):55-62. PubMed ID: 23121976
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus.
    Muller CP, Beauverger P, Schneider F, Jung G, Brons NH.
    J Gen Virol; 1995 Jun 19; 76 ( Pt 6)():1371-80. PubMed ID: 7782766
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.